Paul McKenzie
CIK 1677903 · EVP Pharmaceutical Oper & Tech · last filed 2019-03-05
Paul McKenzie is an EVP Pharmaceutical Oper & Tech who has filed 8 SEC Form 4 insider transactions across 1 company since 2017. The most recent filing, for BIIB, was dated Mar 5, 2019. Current disclosed insider exposure totals $1.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.38M
1
8
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BIIB | EVP Pharmaceutical Oper & Tech | 6,919 | $200.05 | $1.38M | $0 | 8 | 2019-03-05 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-03-05 | BIIB | Mixed | −90 | -$219.8K | EDGAR |
| 2019-02-20 | BIIB | Mixed | +805 | -$214.0K | EDGAR |
| 2019-02-14 | BIIB | Mixed | +2,143 | -$293.6K | EDGAR |
| 2018-03-05 | BIIB | Mixed | −110 | -$181.3K | EDGAR |
| 2018-02-20 | BIIB | Mixed | +1,030 | -$132.3K | EDGAR |
| 2018-02-14 | BIIB | Grant (A) | — | $0 | EDGAR |
| 2017-03-03 | BIIB | Mixed | +3,054 | -$46.0K | EDGAR |
| 2017-02-17 | BIIB | Grant (A) | — | $0 | EDGAR |